Reducing neurodisparity
Recommendations of the 2017 AAN Diversity Leadership Program
Citation Manager Formats

Article Information
- Received March 21, 2018
- Accepted in final form December 6, 2018
- First Published January 18, 2019.
Article Versions
- Previous version (January 18, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Information
- Erika T. Marulanda-Londoño, MD,
- Michelle W. Bell, MD,
- Omotola A. Hope, MD,
- Rodney O. Leacock, MD,
- Cumara B. O'Carroll, MD, MPH,
- Jose Posas III, MD,
- Natividad P. Stover, MD,
- Richard Young, MD, MPH and
- Roy Hamilton, MD, MS
- Erika T. Marulanda-Londoño, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michelle W. Bell, MD,
NONE
NONE
NONE
NONE
NONE
I am in contract with Demos Medical Publishing company for creation of a EEG tutorial atlas mobile app. The app has not been completed as yet and I have not received any royalties as yet. Also the details are being negotiated with Columbia University and all royalties might go to the University.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Omotola A. Hope, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rodney O. Leacock, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cumara B. O'Carroll, MD, MPH,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jose Posas III, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) University of Queensland, Australia School of Medicine Assistant Clinical Professor of Neurology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Natividad P. Stover, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Richard Young, MD, MPH and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Roy Hamilton, MD, MS
1) I am the data safety monitor for an NIH-funded R21 project titled
NONE
NONE
(1)Cognitive and Behavioral Neurology, editorial board member, 2015 to present (2)Restorative Neurology and Neuroscience, editorial board member, 2011 to present
NONE
NONE
Neuronix LTD, Medical consultant, 2014 to present
1) I serve as a consultant for Geurbet Ltd. on the development of an FDA-mandated clinical trial. I have received approximately $6000 for this work in the last 2 years (2017-18).
NONE
NONE
NONE
NONE
NONE
NONE
1) NIH/NIA 5P30-AG-010124-27 Co-Investigator 7/15/97-6/30/19 2) NIH/NIDCD 1 R01 DC012780-01A1 Principal Investigator 7/01/2013 - 6/30/2019 3) NIH/NIDCD 2-R01-DC-009209-11 Co-Investigator 6/01/2014 - 5/31/2019 4) NIH/NIDCR DP5OD021352 Co-Investigator 9/19/2015 - 08/31/2020 5) NIH/NIDCD 1R01DC015359-01A1 Co-Investigator 4/01/2016 - 3/31/2021 6) University of Pennsylvania/Translational Neuroscience Initiative (TNI) Co-Investigator 7/01/2016 - 6/30/2019 . 7) NIH/NEI R01EY022350 Co-Investigator 9/01/2016 - 8/31/2021 8) NIH/NINDS 5P30NS045839-12 Co-Investigator 2/1/2014-1/31/2018 9) Templeton Foundation/Imagination Institute Principal Investigator 7/01/2015 ? 6/30/2017 10) Association for Frontotemporal Dementia Principal Investigator 1/01/2016 ? 12/31/2016 11) Dana Foundation Principal Investigator 12/13/2012 - 4/24/2018
NONE
NONE
NONE
NONE
NONE
Kline & Specter Attorneys at Law, Consultant, 2014, 2015.
- From the Department of Neurology (E.T.M.-L.), University of Miami Miller School of Medicine, FL; Department of Neurology (M.W.B.), Columbia University Medical Center, New York, NY; Department of Neurology (O.A.H.), University of Texas, Houston; Palmetto Health (R.O.L.), University of South Carolina, Columbia; Department of Neurology (C.B.O.), Mayo Clinic College of Medicine, Phoenix, AZ; Department of Neurology (J.P.), Ochsner Health System, New Orleans, LA; Department of Neurology (N.P.S.), University of Alabama at Birmingham; Department of Neurology (R.Y.), University of Connecticut School of Medicine, Farmington; and Department of Neurology (R.H.), University of Pennsylvania, Philadelphia.
- Correspondence
Dr. Hamilton roy.hamilton{at}uphs.upenn.edu
Article usage
Disputes & Debates: Rapid online correspondence
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- Glossary
- Acknowledging the impact of bias
- Strategies for overcoming bias
- Enhancing health literacy and patient-centered education in the digital age
- Strategies for enhancing health literacy and patient-centered education in the digital age
- Promoting research and education in neurodisparity
- Discussion
- Author contributions
- Study funding
- Disclosure
- Acknowledgment
- Footnotes
- References
- Info